William P. Sheridan
Corporate Officer/Principal chez BIOCRYST PHARMACEUTICALS, INC.
Fortune : 30 729 $ au 31/03/2024
Profil
William P.
Sheridan's current job is as the Chief Development Officer at BioCryst Pharmaceuticals, Inc. His former job was as the Vice President-North American Medical Affairs at Amgen, Inc. He also served as the Head-Bone Marrow Transplant Service at Royal Melbourne Hospital.
Dr. Sheridan holds a doctorate degree from the University of Melbourne.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2023 | 6 049 ( 0,00% ) | 30 729 $ | 31/03/2024 |
Postes actifs de William P. Sheridan
| Sociétés | Poste | Début |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 15/09/2022 |
Anciens postes connus de William P. Sheridan
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/11/2007 |
Royal Melbourne Hospital
 Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Formation de William P. Sheridan
| University of Melbourne | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Royal Melbourne Hospital
Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Health Services |
